APO Research
Talk to an analyst

APO RESEARCH · REPORT

Live Attenuated Rotavirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Live Attenuated Rotavirus Vaccine Market Analysis and Forecast 2026-2032

29 December 2025196 pages

Choose your research edition.

Industry ResearchLive Attenuated Rotavirus Vaccine Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Live Attenuated Rotavirus Vaccine Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Live Attenuated Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Live Attenuated Rotavirus Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Live Attenuated Rotavirus Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Live Attenuated Rotavirus Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Live Attenuated Rotavirus Vaccine's global sales reached XX (Units) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Bharat Biotech as the global sales leader, a title it has maintained for several consecutive years. Notably, Bharat Biotech's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Units), a change of XX% from the previous year. In Europe, sales were XX (Units), showing a year-on-year of XX%. In the US, sales were XX (Units), a year-on-year change of XX%.

The major global manufacturers in the Live Attenuated Rotavirus Vaccine market include Bharat Biotech, GSK, Lanzhou Biological Products Research Institute and Merck Sharp & Dohme, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Live Attenuated Rotavirus Vaccine production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Live Attenuated Rotavirus Vaccine by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Live Attenuated Rotavirus Vaccine, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Live Attenuated Rotavirus Vaccine, also provides the consumption of main regions and countries. Of the upcoming market potential for Live Attenuated Rotavirus Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Live Attenuated Rotavirus Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Live Attenuated Rotavirus Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Live Attenuated Rotavirus Vaccine sales, projected growth trends, production technology, application and end-user industry.

Live Attenuated Rotavirus Vaccine Segment by Company

Bharat Biotech

GSK

Lanzhou Biological Products Research Institute

Merck Sharp & Dohme

Live Attenuated Rotavirus Vaccine Segment by Type

Monovalent Vaccines

Combination Vaccines

Live Attenuated Rotavirus Vaccine Segment by Application

Hospitals and Clinics

Vaccination Sites

Live Attenuated Rotavirus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Live Attenuated Rotavirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Live Attenuated Rotavirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Live Attenuated Rotavirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Live Attenuated Rotavirus Vaccine production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Live Attenuated Rotavirus Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Live Attenuated Rotavirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Live Attenuated Rotavirus Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Live Attenuated Rotavirus Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Monovalent Vaccines Major Manufacturers Table 3. Combination Vaccines Major Manufacturers Table 4. Global Live Attenuated Rotavirus Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals and Clinics Major Manufacturers Table 6. Vaccination Sites Major Manufacturers Table 7. Live Attenuated Rotavirus Vaccine Industry Trends Table 8. Live Attenuated Rotavirus Vaccine Industry Drivers Table 9. Live Attenuated Rotavirus Vaccine Industry Opportunities and Challenges Table 10. Live Attenuated Rotavirus Vaccine Industry Restraints Table 11. Global Live Attenuated Rotavirus Vaccine Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 12. Global Live Attenuated Rotavirus Vaccine Production by Region (2021-2026) & (Units) Table 13. Global Live Attenuated Rotavirus Vaccine Production by Region (2027-2032) & (Units) Table 14. Global Live Attenuated Rotavirus Vaccine Production Market Share by Region (2021-2026) Table 15. Global Live Attenuated Rotavirus Vaccine Production Market Share by Region (2027-2032) Table 16. Global Live Attenuated Rotavirus Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Live Attenuated Rotavirus Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Live Attenuated Rotavirus Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2021-2026) Table 20. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2027-2032) Table 21. Global Live Attenuated Rotavirus Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 22. Global Live Attenuated Rotavirus Vaccine Sales by Region (2021-2026) & (Units) Table 23. Global Live Attenuated Rotavirus Vaccine Sales by Region (2027-2032) & (Units) Table 24. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2021-2026) Table 25. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2027-2032) Table 26. Global Live Attenuated Rotavirus Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Live Attenuated Rotavirus Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Manufacturers (2021-2026) Table 30. Global Live Attenuated Rotavirus Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Live Attenuated Rotavirus Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Live Attenuated Rotavirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Live Attenuated Rotavirus Vaccine Manufacturers, Product Type & Application Table 34. Global Live Attenuated Rotavirus Vaccine Manufacturers Commercialization Time Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Live Attenuated Rotavirus Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 37. Global Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Live Attenuated Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2021-2026) Table 40. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2027-2032) Table 41. Global Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (Units) Table 42. Global Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (Units) Table 43. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2026) Table 44. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2027-2032) Table 45. Global Live Attenuated Rotavirus Vaccine Price by Type (2021-2026) & (US$/Unit) Table 46. Global Live Attenuated Rotavirus Vaccine Price by Type (2027-2032) & (US$/Unit) Table 47. Global Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Live Attenuated Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2021-2026) Table 50. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2027-2032) Table 51. Global Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (Units) Table 52. Global Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (Units) Table 53. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2026) Table 54. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2027-2032) Table 55. Global Live Attenuated Rotavirus Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Live Attenuated Rotavirus Vaccine Price by Application (2027-2032) & (US$/Unit) Table 57. Bharat Biotech Company Information Table 58. Bharat Biotech Business Overview Table 59. Bharat Biotech Live Attenuated Rotavirus Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Bharat Biotech Live Attenuated Rotavirus Vaccine Product Portfolio Table 61. Bharat Biotech Recent Development Table 62. GSK Company Information Table 63. GSK Business Overview Table 64. GSK Live Attenuated Rotavirus Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. GSK Live Attenuated Rotavirus Vaccine Product Portfolio Table 66. GSK Recent Development Table 67. Lanzhou Biological Products Research Institute Company Information Table 68. Lanzhou Biological Products Research Institute Business Overview Table 69. Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Product Portfolio Table 71. Lanzhou Biological Products Research Institute Recent Development Table 72. Merck Sharp & Dohme Company Information Table 73. Merck Sharp & Dohme Business Overview Table 74. Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Product Portfolio Table 76. Merck Sharp & Dohme Recent Development Table 77. North America Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 78. North America Live Attenuated Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 79. North America Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (Units) Table 80. North America Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (Units) Table 81. North America Live Attenuated Rotavirus Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 82. North America Live Attenuated Rotavirus Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 83. North America Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 84. North America Live Attenuated Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 85. North America Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (Units) Table 86. North America Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (Units) Table 87. North America Live Attenuated Rotavirus Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 88. North America Live Attenuated Rotavirus Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 89. North America Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 91. North America Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 92. North America Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 93. North America Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (Units) Table 94. North America Live Attenuated Rotavirus Vaccine Sales by Country (2027-2032) & (Units) Table 95. North America Live Attenuated Rotavirus Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 96. North America Live Attenuated Rotavirus Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 97. United States Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 98. Canada Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 99. Mexico Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 100. Europe Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 101. Europe Live Attenuated Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 102. Europe Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (Units) Table 103. Europe Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (Units) Table 104. Europe Live Attenuated Rotavirus Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 105. Europe Live Attenuated Rotavirus Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 106. Europe Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 107. Europe Live Attenuated Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 108. Europe Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (Units) Table 109. Europe Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (Units) Table 110. Europe Live Attenuated Rotavirus Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 111. Europe Live Attenuated Rotavirus Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 112. Europe Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 114. Europe Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 115. Europe Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 116. Europe Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (Units) Table 117. Europe Live Attenuated Rotavirus Vaccine Sales by Country (2027-2032) & (Units) Table 118. Europe Live Attenuated Rotavirus Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 119. Europe Live Attenuated Rotavirus Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 120. Germany Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 121. France Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 122. U.K. Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 123. Italy Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 124. Russia Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 125. Spain Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 126. Netherlands Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 127. Switzerland Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 128. Sweden Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 129. Poland Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 130. China Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 131. China Live Attenuated Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 132. China Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (Units) Table 133. China Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (Units) Table 134. China Live Attenuated Rotavirus Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 135. China Live Attenuated Rotavirus Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 136. China Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 137. China Live Attenuated Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 138. China Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (Units) Table 139. China Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (Units) Table 140. China Live Attenuated Rotavirus Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 141. China Live Attenuated Rotavirus Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 142. Asia Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Live Attenuated Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (Units) Table 145. Asia Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (Units) Table 146. Asia Live Attenuated Rotavirus Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 147. Asia Live Attenuated Rotavirus Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 148. Asia Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia Live Attenuated Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (Units) Table 151. Asia Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (Units) Table 152. Asia Live Attenuated Rotavirus Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 153. Asia Live Attenuated Rotavirus Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 154. Asia Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Asia Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. Asia Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. Asia Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 158. Asia Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (Units) Table 159. Asia Live Attenuated Rotavirus Vaccine Sales by Country (2027-2032) & (Units) Table 160. Asia Live Attenuated Rotavirus Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 161. Asia Live Attenuated Rotavirus Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 162. Japan Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 163. South Korea Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 164. India Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 165. Australia Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 166. Taiwan Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 167. Southeast Asia Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 168. SAMEA Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 169. SAMEA Live Attenuated Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 170. SAMEA Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (Units) Table 171. SAMEA Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (Units) Table 172. SAMEA Live Attenuated Rotavirus Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 173. SAMEA Live Attenuated Rotavirus Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 174. SAMEA Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 175. SAMEA Live Attenuated Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 176. SAMEA Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (Units) Table 177. SAMEA Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (Units) Table 178. SAMEA Live Attenuated Rotavirus Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 179. SAMEA Live Attenuated Rotavirus Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 180. SAMEA Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. SAMEA Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. SAMEA Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. SAMEA Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 184. SAMEA Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (Units) Table 185. SAMEA Live Attenuated Rotavirus Vaccine Sales by Country (2027-2032) & (Units) Table 186. SAMEA Live Attenuated Rotavirus Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 187. SAMEA Live Attenuated Rotavirus Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Brazil Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 189. Argentina Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 190. Chile Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 191. Colombia Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 192. Peru Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 193. Saudi Arabia Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 194. Israel Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 195. UAE Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 196. Turkey Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 197. Iran Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 198. Egypt Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Live Attenuated Rotavirus Vaccine Distributors List Table 202. Live Attenuated Rotavirus Vaccine Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Live Attenuated Rotavirus Vaccine Product Image Figure 2. Global Live Attenuated Rotavirus Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Live Attenuated Rotavirus Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure . Monovalent Vaccines Image Figure 1. Combination Vaccines Image Figure 2. Global Live Attenuated Rotavirus Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Live Attenuated Rotavirus Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hospitals and Clinics Image Figure 5. Vaccination Sites Image Figure 6. Global Live Attenuated Rotavirus Vaccine Capacity, Capacity Utilization (2021-2032) & (Units) Figure 7. Global Live Attenuated Rotavirus Vaccine Production by Region: 2021 VS 2025 VS 2032 (Units) Figure 8. Global Live Attenuated Rotavirus Vaccine Production Market Share by Region: 2025 Versus 2032 Figure 9. Global Live Attenuated Rotavirus Vaccine Production Market Share by Region (2021-2032) Figure 10. North America Live Attenuated Rotavirus Vaccine Production Growth Rate (2021-2032) & (Units) Figure 11. Europe Live Attenuated Rotavirus Vaccine Production Growth Rate (2021-2032) & (Units) Figure 12. China Live Attenuated Rotavirus Vaccine Production Growth Rate (2021-2032) & (Units) Figure 13. Japan Live Attenuated Rotavirus Vaccine Production Growth Rate (2021-2032) & (Units) Figure 14. Global Live Attenuated Rotavirus Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 16. Global Live Attenuated Rotavirus Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2021-2032) Figure 19. Global Live Attenuated Rotavirus Vaccine Sales (2021-2032) & (Units) Figure 20. Global Live Attenuated Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 21. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2021-2032) Figure 22. North America Live Attenuated Rotavirus Vaccine Sales YoY (2021-2032) & (Units) Figure 23. Europe Live Attenuated Rotavirus Vaccine Sales YoY (2021-2032) & (Units) Figure 24. China Live Attenuated Rotavirus Vaccine Sales YoY (2021-2032) & (Units) Figure 25. Asia (Excluding China) Live Attenuated Rotavirus Vaccine Sales YoY (2021-2032) & (Units) Figure 26. South America, Middle East and Africa Live Attenuated Rotavirus Vaccine Sales YoY (2021-2032) & (Units) Figure 27. Global Live Attenuated Rotavirus Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Live Attenuated Rotavirus Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2021-2032) Figure 31. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2021-2032) Figure 33. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2032) Figure 34. North America Live Attenuated Rotavirus Vaccine Revenue Share by Type (2021-2032) Figure 35. North America Live Attenuated Rotavirus Vaccine Sales Share by Type (2021-2032) Figure 36. North America Live Attenuated Rotavirus Vaccine Revenue Share by Application (2021-2032) Figure 37. North America Live Attenuated Rotavirus Vaccine Sales Share by Application (2021-2032) Figure 38. North America Live Attenuated Rotavirus Vaccine Revenue Share by Country (2021-2032) Figure 39. North America Live Attenuated Rotavirus Vaccine Sales Share by Country (2021-2032) Figure 40. Europe Live Attenuated Rotavirus Vaccine Revenue Share by Type (2021-2032) Figure 41. Europe Live Attenuated Rotavirus Vaccine Sales Share by Type (2021-2032) Figure 42. Europe Live Attenuated Rotavirus Vaccine Revenue Share by Application (2021-2032) Figure 43. Europe Live Attenuated Rotavirus Vaccine Sales Share by Application (2021-2032) Figure 44. Europe Live Attenuated Rotavirus Vaccine Revenue Share by Country (2021-2032) Figure 45. Europe Live Attenuated Rotavirus Vaccine Sales Share by Country (2021-2032) Figure 46. China Live Attenuated Rotavirus Vaccine Revenue Share by Type (2021-2032) Figure 47. China Live Attenuated Rotavirus Vaccine Sales Share by Type (2021-2032) Figure 48. China Live Attenuated Rotavirus Vaccine Revenue Share by Application (2021-2032) Figure 49. China Live Attenuated Rotavirus Vaccine Sales Share by Application (2021-2032) Figure 50. Asia Live Attenuated Rotavirus Vaccine Revenue Share by Type (2021-2032) Figure 51. Asia Live Attenuated Rotavirus Vaccine Sales Share by Type (2021-2032) Figure 52. Asia Live Attenuated Rotavirus Vaccine Revenue Share by Application (2021-2032) Figure 53. Asia Live Attenuated Rotavirus Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Live Attenuated Rotavirus Vaccine Revenue Share by Country (2021-2032) Figure 55. Asia Live Attenuated Rotavirus Vaccine Sales Share by Country (2021-2032) Figure 56. SAMEA Live Attenuated Rotavirus Vaccine Revenue Share by Type (2021-2032) Figure 57. SAMEA Live Attenuated Rotavirus Vaccine Sales Share by Type (2021-2032) Figure 58. SAMEA Live Attenuated Rotavirus Vaccine Revenue Share by Application (2021-2032) Figure 59. SAMEA Live Attenuated Rotavirus Vaccine Sales Share by Application (2021-2032) Figure 60. SAMEA Live Attenuated Rotavirus Vaccine Revenue Share by Country (2021-2032) Figure 61. SAMEA Live Attenuated Rotavirus Vaccine Sales Share by Country (2021-2032) Figure 62. Live Attenuated Rotavirus Vaccine Value Chain Figure 63. Manufacturing Cost Structure Figure 64. Live Attenuated Rotavirus Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccines
  • Combination Vaccines
Applications
  • Hospitals and Clinics
  • Vaccination Sites
Companies covered
  • Bharat Biotech
  • GSK
  • Lanzhou Biological Products Research Institute
  • Merck Sharp & Dohme

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Live Attenuated Rotavirus Vaccine Market by Type
  3. 1.2.1 Global Live Attenuated Rotavirus Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Monovalent Vaccines
  5. 1.2.3 Combination Vaccines
  6. 1.3 Live Attenuated Rotavirus Vaccine Market by Application
  7. 1.3.1 Global Live Attenuated Rotavirus Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals and Clinics
  9. 1.3.3 Vaccination Sites
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Live Attenuated Rotavirus Vaccine Market Dynamics
  1. 2.1 Live Attenuated Rotavirus Vaccine Industry Trends
  2. 2.2 Live Attenuated Rotavirus Vaccine Industry Drivers
  3. 2.3 Live Attenuated Rotavirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Live Attenuated Rotavirus Vaccine Industry Restraints
3 Global Live Attenuated Rotavirus Vaccine Production Overview
  1. 3.1 Global Live Attenuated Rotavirus Vaccine Production Capacity (2021-2032)
  2. 3.2 Global Live Attenuated Rotavirus Vaccine Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Live Attenuated Rotavirus Vaccine Production by Region
  4. 3.3.1 Global Live Attenuated Rotavirus Vaccine Production by Region (2021-2026)
  5. 3.3.2 Global Live Attenuated Rotavirus Vaccine Production by Region (2027-2032)
  6. 3.3.3 Global Live Attenuated Rotavirus Vaccine Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Live Attenuated Rotavirus Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Live Attenuated Rotavirus Vaccine Revenue by Region
  3. 4.2.1 Global Live Attenuated Rotavirus Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Live Attenuated Rotavirus Vaccine Revenue by Region (2021-2026)
  5. 4.2.3 Global Live Attenuated Rotavirus Vaccine Revenue by Region (2027-2032)
  6. 4.2.4 Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Live Attenuated Rotavirus Vaccine Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Live Attenuated Rotavirus Vaccine Sales by Region
  9. 4.4.1 Global Live Attenuated Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Live Attenuated Rotavirus Vaccine Sales by Region (2021-2026)
  11. 4.4.3 Global Live Attenuated Rotavirus Vaccine Sales by Region (2027-2032)
  12. 4.4.4 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Live Attenuated Rotavirus Vaccine Revenue by Manufacturers
  2. 5.1.1 Global Live Attenuated Rotavirus Vaccine Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Live Attenuated Rotavirus Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Live Attenuated Rotavirus Vaccine Sales by Manufacturers
  6. 5.2.1 Global Live Attenuated Rotavirus Vaccine Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Live Attenuated Rotavirus Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Live Attenuated Rotavirus Vaccine Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Live Attenuated Rotavirus Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Live Attenuated Rotavirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Live Attenuated Rotavirus Vaccine Manufacturers, Product Type & Application
  13. 5.7 Global Live Attenuated Rotavirus Vaccine Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Live Attenuated Rotavirus Vaccine Market CR5 and HHI
  16. 5.8.2 2025 Live Attenuated Rotavirus Vaccine Tier 1, Tier 2, and Tier 3
6 Live Attenuated Rotavirus Vaccine Market by Type
  1. 6.1 Global Live Attenuated Rotavirus Vaccine Revenue by Type
  2. 6.1.1 Global Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Live Attenuated Rotavirus Vaccine Sales by Type
  5. 6.2.1 Global Live Attenuated Rotavirus Vaccine Sales by Type (2021-2032) & (Units)
  6. 6.2.2 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2032)
  7. 6.3 Global Live Attenuated Rotavirus Vaccine Price by Type
7 Live Attenuated Rotavirus Vaccine Market by Application
  1. 7.1 Global Live Attenuated Rotavirus Vaccine Revenue by Application
  2. 7.1.1 Global Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Live Attenuated Rotavirus Vaccine Sales by Application
  5. 7.2.1 Global Live Attenuated Rotavirus Vaccine Sales by Application (2021-2032) & (Units)
  6. 7.2.2 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2032)
  7. 7.3 Global Live Attenuated Rotavirus Vaccine Price by Application
8 Company Profiles
  1. 8.1 Bharat Biotech
  2. 8.1.1 Bharat Biotech Company Information
  3. 8.1.2 Bharat Biotech Business Overview
  4. 8.1.3 Bharat Biotech Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Bharat Biotech Live Attenuated Rotavirus Vaccine Product Portfolio
  6. 8.1.5 Bharat Biotech Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 GSK Live Attenuated Rotavirus Vaccine Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Lanzhou Biological Products Research Institute
  14. 8.3.1 Lanzhou Biological Products Research Institute Company Information
  15. 8.3.2 Lanzhou Biological Products Research Institute Business Overview
  16. 8.3.3 Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Product Portfolio
  18. 8.3.5 Lanzhou Biological Products Research Institute Recent Developments
  19. 8.4 Merck Sharp & Dohme
  20. 8.4.1 Merck Sharp & Dohme Company Information
  21. 8.4.2 Merck Sharp & Dohme Business Overview
  22. 8.4.3 Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Product Portfolio
  24. 8.4.5 Merck Sharp & Dohme Recent Developments
9 North America
  1. 9.1 North America Live Attenuated Rotavirus Vaccine Market Size by Type
  2. 9.1.1 North America Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 North America Live Attenuated Rotavirus Vaccine Sales by Type (2021-2032)
  4. 9.1.3 North America Live Attenuated Rotavirus Vaccine Price by Type (2021-2032)
  5. 9.2 North America Live Attenuated Rotavirus Vaccine Market Size by Application
  6. 9.2.1 North America Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 North America Live Attenuated Rotavirus Vaccine Sales by Application (2021-2032)
  8. 9.2.3 North America Live Attenuated Rotavirus Vaccine Price by Application (2021-2032)
  9. 9.3 North America Live Attenuated Rotavirus Vaccine Market Size by Country
  10. 9.3.1 North America Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Live Attenuated Rotavirus Vaccine Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Live Attenuated Rotavirus Vaccine Market Size by Type
  2. 10.1.1 Europe Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 Europe Live Attenuated Rotavirus Vaccine Sales by Type (2021-2032)
  4. 10.1.3 Europe Live Attenuated Rotavirus Vaccine Price by Type (2021-2032)
  5. 10.2 Europe Live Attenuated Rotavirus Vaccine Market Size by Application
  6. 10.2.1 Europe Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 Europe Live Attenuated Rotavirus Vaccine Sales by Application (2021-2032)
  8. 10.2.3 Europe Live Attenuated Rotavirus Vaccine Price by Application (2021-2032)
  9. 10.3 Europe Live Attenuated Rotavirus Vaccine Market Size by Country
  10. 10.3.1 Europe Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Live Attenuated Rotavirus Vaccine Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Live Attenuated Rotavirus Vaccine Market Size by Type
  2. 11.1.1 China Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 China Live Attenuated Rotavirus Vaccine Sales by Type (2021-2032)
  4. 11.1.3 China Live Attenuated Rotavirus Vaccine Price by Type (2021-2032)
  5. 11.2 China Live Attenuated Rotavirus Vaccine Market Size by Application
  6. 11.2.1 China Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 China Live Attenuated Rotavirus Vaccine Sales by Application (2021-2032)
  8. 11.2.3 China Live Attenuated Rotavirus Vaccine Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Live Attenuated Rotavirus Vaccine Market Size by Type
  2. 12.1.1 Asia Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 Asia Live Attenuated Rotavirus Vaccine Sales by Type (2021-2032)
  4. 12.1.3 Asia Live Attenuated Rotavirus Vaccine Price by Type (2021-2032)
  5. 12.2 Asia Live Attenuated Rotavirus Vaccine Market Size by Application
  6. 12.2.1 Asia Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 Asia Live Attenuated Rotavirus Vaccine Sales by Application (2021-2032)
  8. 12.2.3 Asia Live Attenuated Rotavirus Vaccine Price by Application (2021-2032)
  9. 12.3 Asia Live Attenuated Rotavirus Vaccine Market Size by Country
  10. 12.3.1 Asia Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Live Attenuated Rotavirus Vaccine Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Live Attenuated Rotavirus Vaccine Market Size by Type
  2. 13.1.1 SAMEA Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Live Attenuated Rotavirus Vaccine Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Live Attenuated Rotavirus Vaccine Price by Type (2021-2032)
  5. 13.2 SAMEA Live Attenuated Rotavirus Vaccine Market Size by Application
  6. 13.2.1 SAMEA Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Live Attenuated Rotavirus Vaccine Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Live Attenuated Rotavirus Vaccine Price by Application (2021-2032)
  9. 13.3 SAMEA Live Attenuated Rotavirus Vaccine Market Size by Country
  10. 13.3.1 SAMEA Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Live Attenuated Rotavirus Vaccine Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Live Attenuated Rotavirus Vaccine Value Chain Analysis
  2. 14.1.1 Live Attenuated Rotavirus Vaccine Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Live Attenuated Rotavirus Vaccine Production Mode & Process
  6. 14.2 Live Attenuated Rotavirus Vaccine Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Live Attenuated Rotavirus Vaccine Distributors
  9. 14.2.3 Live Attenuated Rotavirus Vaccine Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst